Publication Document

Please enter search criteria

Document Type

Issuer / Underlying / Securities

Date From

The Financial Statements which need to be revised ( 0 record(s) found)

Order Date	Company Name	Reviewed Financial Statement	Details
Data not found

Finanacial Statements ( 54 record(s) found)

Name	Year	Status	Type	Period	As Of
INTER PHARMA PUBLIC COMPANY LIMITED	2025	Reviewed	Consolidated	Q3	30/09/2025
INTER PHARMA PUBLIC COMPANY LIMITED	2025	Reviewed	Company	Q3	30/09/2025
INTER PHARMA PUBLIC COMPANY LIMITED	2025	Reviewed	Consolidated	Q2	30/06/2025
INTER PHARMA PUBLIC COMPANY LIMITED	2025	Reviewed	Company	Q2	30/06/2025
INTER PHARMA PUBLIC COMPANY LIMITED	2025	Reviewed	Consolidated	Q1	31/03/2025
INTER PHARMA PUBLIC COMPANY LIMITED	2025	Reviewed	Company	Q1	31/03/2025
INTER PHARMA PUBLIC COMPANY LIMITED	2024	Audited	Consolidated	Year	31/12/2024
INTER PHARMA PUBLIC COMPANY LIMITED	2024	Audited	Company	Year	31/12/2024
INTER PHARMA PUBLIC COMPANY LIMITED	2024	Reviewed	Consolidated	Q3	30/09/2024
INTER PHARMA PUBLIC COMPANY LIMITED	2024	Reviewed	Company	Q3	30/09/2024

Key Financial Ratio ( 0 record(s) found)

Name	Business Type	Type	Period	Year	As Of	Details
Data not found

Management's Discussion and Analysis ( 12 record(s) found)

Date	Time	Heading
11/11/2025	18:28	Management Discussion and Analysis Quarter 3 Ending 30 Sep 2025
14/08/2025	17:01	Management Discussion and Analysis Quarter 2 Ending 30 Jun 2025
13/05/2025	08:31	Management Discussion and Analysis Quarter 1 Ending 31 Mar 2025
25/02/2025	21:14	Management Discussion and Analysis Yearly Ending 31 Dec 2024
14/11/2024	20:09	Management Discussion and Analysis Quarter 3 Ending 30 Sep 2024
14/08/2024	19:32	Management Discussion and Analysis Quarter 2 Ending 30 Jun 2024
14/05/2024	08:20	Management Discussion and Analysis Quarter 1 Ending 31 Mar 2024
01/03/2024	08:01	Management Discussion and Analysis Yearly Ending 31 Dec 2023
14/11/2023	08:16	Management Discussion and Analysis Quarter 3 Ending 30 Sep 2023
10/08/2023	21:00	Management Discussion and Analysis Quarter 2 Ending 30 Jun 2023

SEC has ordered to amend Finanacial Statements ( 0 record(s) found)

Name	Description	Details
Data not found